Bioxcel Therapeutics's total assets for Q1 2025 were $38.57M, an increase of 0.59% from the previous quarter. BTAI total liabilities were $128.74M for the fiscal quarter, a -2.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.